Equities

Shoulder Innovations Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shoulder Innovations Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)13.01
  • Today's Change-0.02 / -0.15%
  • Shares traded83.02k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Mar 06 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.

  • Revenue in USD (TTM)41.63m
  • Net income in USD-34.45m
  • Incorporated2009
  • Employees61.00
  • Location
    Shoulder Innovations Inc1535 Steele Avenue SW, Suite BGRAND RAPIDS 49507United StatesUSA
  • Phone+1 (616) 566-0286
  • Fax+1 (302) 655-5049
  • Websitehttps://shoulderinnovations.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CVRx Inc56.65m-53.31m217.07m223.00--5.52--3.83-2.04-2.042.171.490.47560.68375.68254,040.40-44.76-39.12-49.79-42.1085.3382.74-94.10-130.776.72-8.800.5574--10.4556.4011.10--13.27--
908 Devices Inc56.20m-33.27m226.57m246.00--1.58--4.03-0.93820.55371.543.970.32151.904.69---19.04-17.00-22.92-18.8750.5852.42-59.21-73.413.86------17.7015.8837.38------
OraSure Technologies Inc125.70m-60.24m228.83m501.00--0.6369--1.82-0.8107-0.81071.695.010.28342.074.91250,904.20-13.08-0.8506-14.16-0.959640.4144.80-46.15-1.396.20--0.0005---54.173.75-136.34---16.43--
Quanterix Corp138.90m-107.15m237.52m450.00--0.7998--1.71-2.52-2.523.266.330.33661.694.47308,660.00-25.97-15.56-30.25-17.2546.7754.07-77.14-53.542.11--0.00--1.079.97-178.09---7.85--
CapsoVision Inc13.09m-22.56m239.84m----11.72--18.32-0.4873-0.48730.28260.4368----------------53.13---172.37--4.50--0.00--20.54---76.01------
Orchestra Biomed Holdings Inc2.82m-75.10m243.93m70.00--5.58--86.56-1.82-1.820.06760.77460.03130.657833.7540,257.14-83.39---104.85--93.01---2,665.05--4.72--0.2451---4.42---24.23------
Simulations Plus Inc78.68m-64.25m246.19m212.00--1.94--3.13-3.20-3.203.906.310.4701--4.28371,113.20-38.39-2.50-40.84-2.6559.6069.96-81.66-7.29----0.00--13.0913.74-750.17--7.57-24.21
Senseonics Holdings Inc35.26m-69.11m248.95m130.00--4.03--7.06-1.65-1.650.84541.480.3113.503.83271,207.70-60.97-52.92-84.54-64.6644.7119.33-196.03-334.424.55-90.750.3683--56.8948.1012.09--43.88--
Shoulder Innovations Inc41.63m-34.45m268.03m61.00--1.81--6.44-1.91-1.912.247.18----------------76.67---82.75--9.80--0.0913--64.07---50.85------
Applied Energetics Inc1.15m-13.02m279.31m21.00------242.23-0.0599-0.05990.0053-0.00330.3065--7.7054,908.57-345.27-139.08-454.84-208.3658.5860.61-1,126.59-473.16---------7.78---24.71--51.42--
Trubridge Inc349.88m5.42m282.02m3.20k50.661.568.800.8060.37090.370924.2312.020.8737257.086.17109,338.401.39-0.91071.60-1.0353.1650.131.59-1.141.902.400.4768--0.9464.5256.05--61.10--
Clearpoint Neuro Inc34.33m-23.14m297.48m115.00--17.91--8.66-0.8264-0.82641.230.55840.68291.957.52298,539.10-46.03-35.94-54.48-41.4861.3163.49-67.40-74.875.56-92.370.6479--31.0422.8514.37--11.41--
Delcath Systems Inc85.23m2.70m315.50m156.00144.702.83107.383.700.06280.06282.183.210.85141.377.53546,352.602.70-54.432.95-69.7186.1684.723.17-102.109.98--0.00--129.08120.21110.23--14.62--
Rxsight Inc134.48m-38.94m317.34m461.00--1.15--2.36-0.9533-0.95333.296.680.42671.175.03291,713.70-12.36-21.94-13.47-24.1076.6064.71-28.96-52.979.75--0.0003---3.8955.74-41.85--8.57--
Data as of Mar 06 2026. Currency figures normalised to Shoulder Innovations Inc's reporting currency: US Dollar USD

Institutional shareholders

28.42%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Dec 20253.66m17.98%
Sectoral Asset Management, Inc.as of 31 Dec 2025492.44k2.42%
TimesSquare Capital Management LLCas of 31 Dec 2025289.85k1.42%
BlackRock Fund Advisorsas of 31 Dec 2025285.95k1.40%
Alyeska Investment Group LPas of 31 Dec 2025232.98k1.14%
Sio Capital Management LLCas of 31 Dec 2025227.97k1.12%
The Vanguard Group, Inc.as of 31 Dec 2025183.98k0.90%
Roubaix Capital LLCas of 31 Dec 2025158.82k0.78%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025144.10k0.71%
Geode Capital Management LLCas of 31 Dec 2025110.30k0.54%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.